HOME › DRUGS › CARFILZOMIB
ACTIVE SUBSTANCE / INN

CARFILZOMIB

Brand name(s): KYPROLIS, CARFILZOMIB, Kyprolis
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
Multiple Myeloma
ANDA211185
ACTIVE SUBSTANCE
Carfilzomib
REGULATORS
FDA · EMA
SPONSORS / MAH
ONYX PHARMS AMGEN, MSN PHARMACEUTICALS INC, DR REDDYS
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
KYPROLISNDA202714ONYX PHARMS AMGENPrescription
CARFILZOMIBANDA209422DR REDDYSPrescription
CARFILZOMIBANDA209526MSN PHARMACEUTICALS INCNone (Tentative Approval)
CARFILZOMIBANDA211185APOTEXDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
KyprolisAmgen Europe B.V.Authorised19/11/2015Multiple Myeloma

FULL INTELLIGENCE ON CARFILZOMIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →